EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A Rare Case of Cutaneous Extramedullary Hematopoiesis in Chronic Myeloid Leukemia

Bennett Christie-Nguyen iD, Hanadi El Achi, Levani Iashvili, Amer Wahed, Brenda Mai iD, Jacob Armstrong

Journal of Cutaneous Pathology · 2026-09 · 53 (9) · 767-771

DOI: 10.1111/cup.70114 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 10.04.2026. Verfasst von Bennett Christie-Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, U…. Hauptthemen laut MEDLINE: Hematopoiesis, Extramedullary, Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous extramedullary hematopoiesis (CEH) is a rare manifestation of extramedullary hematopoiesis (EMH), a process typically associated with fetal development or myeloproliferative neoplasms. EMH most commonly involves the spleen, liver, and lymph nodes, with CEH being exceedingly rare in chronic myeloid leukemia (CML). Here, we present a 34‐year‐old Hispanic male with multiple bilateral lower extremity lesions, right buttock and leg pain, fatigue, and splenomegaly, who was found to have chronic‐phase CML. Punch biopsy of one of the skin lesions demonstrated dermal infiltration by maturing hematopoietic elements, including granulocytes, megakaryocytes, and erythroid precursors, with fluorescence in situ hybridization (FISH) testing confirming a neoplastic extramedullary hematopoietic infiltrate with the presence of BCR::ABL1 fusion. Initial treatment included hydroxyurea and dasatinib; however, after chronic‐phase CML was confirmed, therapy was transitioned to imatinib, resulting in resolution of B symptoms, normalization of WBC counts, and reduced leg swelling. This case underscores the importance of distinguishing CEH from aggressive disease states, such as blast‐phase CML or myeloid sarcoma, through comprehensive histopathological and immunohistochemical analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoiesis, ExtramedullaryLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHumansMaleAdultDasatinibImatinib MesylateIn Situ Hybridization, Fluorescence

Substanzen

DasatinibImatinib Mesylate

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA.

ORCID-Profile: Bennett Christie-Nguyen, Brenda Mai

Zitieren

APA

Christie-Nguyen, B., El Achi, H., Iashvili, L., Wahed, A., Mai, B., & Armstrong, J. (2026). A Rare Case of Cutaneous Extramedullary Hematopoiesis in Chronic Myeloid Leukemia. Journal of Cutaneous Pathology, 53(9), 767-771. https://doi.org/10.1111/cup.70114

Vancouver

Christie-Nguyen B, El Achi H, Iashvili L, Wahed A, Mai B, Armstrong J. A Rare Case of Cutaneous Extramedullary Hematopoiesis in Chronic Myeloid Leukemia. Journal of Cutaneous Pathology. 2026;53(9):767-771. doi:10.1111/cup.70114

BibTeX
@article{ChristieNguyen2026,
  author = {Christie-Nguyen, Bennett and El Achi, Hanadi and Iashvili, Levani and Wahed, Amer and Mai, Brenda and Armstrong, Jacob},
  title = {A Rare Case of Cutaneous Extramedullary Hematopoiesis in Chronic Myeloid Leukemia},
  journal = {Journal of Cutaneous Pathology},
  year = {2026},
  volume = {53},
  number = {9},
  pages = {767--771},
  doi = {10.1111/cup.70114}
}
Kostenlos starten →